Literature DB >> 21941423

Contrast-enhanced multiple-phase imaging features in hepatic epithelioid hemangioendothelioma.

Ying Chen1, Ri-Sheng Yu, Ling-Ling Qiu, Ding-Yao Jiang, Yan-Bin Tan, Yan-Biao Fu.   

Abstract

AIM: To investigate and review the contrast-enhanced multiple-phase computed tomography (CEMP CT) and magnetic resonance imaging (MRI) findings in patients with pathologically confirmed hepatic epithelioid hemangioendothelioma (HEHE).
METHODS: Findings from imaging examinations in 8 patients (5 women and 3 men) with pathologically confirmed HEHE were retrospectively reviewed (CT images obtained from 7 patients and MR images obtained from 6 patients). The age of presentation varied from 27 years to 60 years (average age 39.8 years).
RESULTS: There were two types of HEHE: multifocal type (n = 7) and diffuse type (n = 1). In the multifocal-type cases, there were 74 lesions on CT and 28 lesions on MRI with 7 lesions found with diffusion weighted imaging; 18 (24.3%) of 74 lesions on plain CT and 26 (92.9%) of 28 lesions on pre-contrast MRI showed the target sign. On CEMP CT, 28 (37.8%) of 74 lesions appeared with the target sign and a progressive-enhancement rim and 9 (12.2%) of 74 lesions displayed progressive enhancement, maintaining a state of persistent enhancement. On CEMP MRI, 27 (96.4%) of 28 lesions appeared with the target sign with a progressive-enhancement rim and 28 (100%) of 28 lesions displayed progressive-enhancement, maintaining a state of persistent enhancement. In the diffuse-type cases, an enlarged liver was observed with a large nodule appearing with persistent enhancement on CEMP CT and MRI.
CONCLUSION: The most important imaging features of HEHE are the target sign and/or progressive enhancement with persistent enhancement on CEMP CT and MRI. MRI is advantageous over CT in displaying these imaging features.

Entities:  

Keywords:  Computed tomography; Epithelioid hemangioendothelioma; Liver; Magnetic resonance imaging; Neoplasm

Mesh:

Substances:

Year:  2011        PMID: 21941423      PMCID: PMC3163254          DOI: 10.3748/wjg.v17.i30.3544

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Hepatic epithelioid hemangioendothelioma: findings at CT and MRI including preliminary observations at diffusion-weighted echo-planar imaging.

Authors:  Melanie Bruegel; Daniela Muenzel; Simone Waldt; Katja Specht; Ernst J Rummeny
Journal:  Abdom Imaging       Date:  2011-08

Review 2.  Hepatic epithelioid hemangioendothelioma.

Authors:  K Uchimura; M Nakamuta; M Osoegawa; S Takeaki; H Nishi; H Iwamoto; M Enjoji; H Nawata
Journal:  J Clin Gastroenterol       Date:  2001 May-Jun       Impact factor: 3.062

3.  Malignant epithelioid hemangioendothelioma of the liver, spreading through the hepatic veins.

Authors:  M Fukayama; Z Nihei; T Takizawa; K Kawaguchi; H Harada; M Koike
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

4.  Hepatic metastases in a case of intravascular bronchioloalveolar tumour.

Authors:  A Gledhill; J M Kay
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

5.  Epithelioid haemangioendothelioma. A case report.

Authors:  D Clements; S Hubscher; R West; E Elias; P McMaster
Journal:  J Hepatol       Date:  1986       Impact factor: 25.083

6.  Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases.

Authors:  K G Ishak; I A Sesterhenn; Z D Goodman; L Rabin; F W Stromeyer
Journal:  Hum Pathol       Date:  1984-09       Impact factor: 3.466

7.  Intravascular, bronchiolar, and alveolar tumor of the lung (IVBAT). An analysis of twenty cases of a peculiar sclerosing endothelial tumor.

Authors:  D H Dail; A A Liebow; J T Gmelich; P J Friedman; K Miyai; W Myer; S D Patterson; S P Hammar
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

8.  Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma.

Authors:  S W Weiss; F M Enzinger
Journal:  Cancer       Date:  1982-09-01       Impact factor: 6.860

Review 9.  The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature.

Authors:  G Y Locker; J H Doroshow; L A Zwelling; B A Chabner
Journal:  Medicine (Baltimore)       Date:  1979-01       Impact factor: 1.889

10.  Intravascular and sclerosing bronchioloalveolar tumor. A pulmonary sarcoma of probable vascular origin.

Authors:  N Azumi; A Churg
Journal:  Am J Surg Pathol       Date:  1981-09       Impact factor: 6.394

View more
  12 in total

1.  Malignant epithelioid hemangioendothelioma: a case report.

Authors:  Khouloud Bouslama; Fatma Houissa; Majd Ben Rejeb; Slim Bouzaidi; Leila Moualhi; Haifa Mekki; Radhouane Dabbeche; Mohamed Salem; Taoufik Najjar
Journal:  Oman Med J       Date:  2013-03

2.  Contrast-enhanced ultrasound of histologically proven hepatic epithelioid hemangioendothelioma.

Authors:  Yi Dong; Wen-Ping Wang; Vito Cantisani; Mirko D'Onofrio; Andre Ignee; Lorenzo Mulazzani; Adrian Saftoiu; Zeno Sparchez; Ioan Sporea; Christoph F Dietrich
Journal:  World J Gastroenterol       Date:  2016-05-21       Impact factor: 5.742

3.  Differentiating primary hepatic angiosarcomas from hemangiomatosis and epithelioid hemangioendotheliomas using gadoxetic acid-enhanced and diffusion-weighted MR imaging.

Authors:  Jung Wook Seo; Seong Hyun Kim; Ah Yeong Kim; Woo Kyoung Jeong; Ji Young Woo; Won Jeong Park
Journal:  Jpn J Radiol       Date:  2017-09-06       Impact factor: 2.374

4.  Gray scale and contrast-enhanced ultrasound imaging of malignant liver tumors of vascular origin.

Authors:  Nora Schweitzer; Bisharah Soudah; Michael Gebel; Michael Peter Manns; Bita Boozari
Journal:  United European Gastroenterol J       Date:  2015-02       Impact factor: 4.623

5.  Hepatic epithelioid hemangioendothelioma: a report from three university centers.

Authors:  Antonello Giardino; Frank H Miller; Bobby Kalb; Miguel Ramalho; Diego R Martin; Karina Rodacki; John T Woosley; Richard C Semelka
Journal:  Radiol Bras       Date:  2016 Sep-Oct

6.  Efficacy and Safety of Interferon-Alpha 2b for Patients with Hepatic Epithelioid Hemangioendothelioma: Outcomes of a Case-Series Analysis.

Authors:  Xiaolei Liu; Zihuan Zhang; Jia Huang; Haidong Tan; Zhiying Yang
Journal:  Cancer Manag Res       Date:  2021-11-03       Impact factor: 3.989

Review 7.  Imaging of multifocal liver lesions in children and adolescents.

Authors:  Shilpa V Hegde; Jonathan R Dillman; Maclovio J Lopez; Peter J Strouse
Journal:  Cancer Imaging       Date:  2013-02-08       Impact factor: 3.909

8.  Hepatic epithelioid hemangioendothelioma: A comparison of Western and Chinese methods with respect to diagnosis, treatment and outcome.

Authors:  Xin Yan Zhao; Mohmedmohsin Ismail Ahmed Rakhda; Sohail Habib; Ali Bihi; Abdullah Muhammad; Tai Ling Wang; Ji-Dong Jia
Journal:  Oncol Lett       Date:  2014-02-03       Impact factor: 2.967

9.  Typical CT and MRI signs of hepatic epithelioid hemangioendothelioma.

Authors:  L U Gan; Ruiping Chang; Hualan Jin; L I Yang
Journal:  Oncol Lett       Date:  2016-01-26       Impact factor: 2.967

Review 10.  Imaging findings of hepatic epithelioid hemangioendothelioma and fibrolamellar hepatocellular carcinoma: a critical appraisal of current literature about imaging features of two rare liver cancers.

Authors:  Lorenzo Mulazzani; Margherita Alvisi
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.